Suppr超能文献

FBXW2 通过泛素化 NF-κB p65 抑制乳腺癌干细胞特性、肿瘤发生和紫杉醇耐药性。

Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance.

机构信息

Department of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, PR China.

Department of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, PR China.

出版信息

Cell Death Differ. 2022 Feb;29(2):381-392. doi: 10.1038/s41418-021-00862-4. Epub 2021 Aug 31.

Abstract

The F-box and WD-repeat-containing protein 2 (FBXW2) plays a crucial role as an E3 ligase in regulating tumorigenesis. However, the functions of FBXW2 in breast cancer are still unknown. Here, we find that nuclear factor-kB (NF-κB) p65 is a new substrate of FBXW2. FBXW2 directly binds to p65, leading to its ubiquitination and degradation. Interestingly, p300 acetylation of p65 blocks FBXW2 induced p65 ubiquitination. FBXW2-p65 axis is a crucial regulator of SOX2-induced stemness in breast cancer. Moreover, FBXW2 inhibits breast tumor growth by regulating p65 degradation in vitro and in vivo. FBXW2 overexpression abrogates the effects of p65 on paclitaxel resistance in vitro and in vivo. Furthermore, FBXW2 induced p65 degradation is also confirmed in FBXW2-knockout mice. Our results identify FBXW2 as an important E3 ligase for p65 degradation, which provide insights into the tumor suppressor functions of FBXW2 in breast cancer.

摘要

F-box 和 WD 重复蛋白 2(FBXW2)作为 E3 连接酶在调节肿瘤发生中起着至关重要的作用。然而,FBXW2 在乳腺癌中的功能仍不清楚。在这里,我们发现核因子-κB(NF-κB)p65 是 FBXW2 的一个新底物。FBXW2 直接与 p65 结合,导致其泛素化和降解。有趣的是,p65 的 p300 乙酰化阻止了 FBXW2 诱导的 p65 泛素化。FBXW2-p65 轴是乳腺癌中 SOX2 诱导干性的关键调节因子。此外,FBXW2 通过调节体外和体内 p65 的降解来抑制乳腺癌肿瘤的生长。FBXW2 过表达消除了 p65 在体外和体内对紫杉醇耐药性的影响。此外,在 FBXW2 敲除小鼠中也证实了 FBXW2 诱导的 p65 降解。我们的研究结果确定 FBXW2 是 p65 降解的重要 E3 连接酶,这为 FBXW2 在乳腺癌中的肿瘤抑制功能提供了新的见解。

相似文献

1
Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance.
Cell Death Differ. 2022 Feb;29(2):381-392. doi: 10.1038/s41418-021-00862-4. Epub 2021 Aug 31.
2
The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20528-20538. doi: 10.1073/pnas.1905973116. Epub 2019 Sep 23.
4
FBXW2 suppresses breast tumorigenesis by targeting AKT-Moesin-SKP2 axis.
Cell Death Dis. 2023 Sep 22;14(9):623. doi: 10.1038/s41419-023-06127-x.
5
7
Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.
Oncogene. 2014 Apr 10;33(15):1997-2003. doi: 10.1038/onc.2013.135. Epub 2013 Apr 29.
9
NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein.
Neoplasia. 2017 Sep;19(9):672-683. doi: 10.1016/j.neo.2017.06.002. Epub 2017 Aug 1.

引用本文的文献

1
A novel SWI/SNF complex promotes triple-negative breast cancer progression.
Cell Mol Biol Lett. 2025 Sep 1;30(1):105. doi: 10.1186/s11658-025-00788-6.
2
NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy.
Front Oncol. 2025 Jul 25;15:1565760. doi: 10.3389/fonc.2025.1565760. eCollection 2025.
3
FOXP2 suppresses gastric cancer progression by transcriptionally repressing FBXW2 via WASL degradation.
Cell Death Discov. 2025 Jul 28;11(1):348. doi: 10.1038/s41420-025-02643-1.
4
Fbxo16 mediates degradation of NF-κB p65 subunit and inhibits inflammatory response in dendritic cells.
Front Immunol. 2025 Jun 3;16:1524110. doi: 10.3389/fimmu.2025.1524110. eCollection 2025.
7
YEATS2: a novel cancer epigenetic reader and potential therapeutic target.
Cancer Cell Int. 2025 Apr 26;25(1):162. doi: 10.1186/s12935-025-03797-9.
8
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential.
Mol Oncol. 2025 Aug;19(8):2174-2195. doi: 10.1002/1878-0261.70033. Epub 2025 Apr 14.
9
FBXW2 inhibits the progression of gastric cancer via promoting β-catenin ubiquitylation.
Int J Med Sci. 2025 Mar 24;22(8):1936-1943. doi: 10.7150/ijms.108501. eCollection 2025.

本文引用的文献

2
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.
Signal Transduct Target Ther. 2020 Sep 21;5(1):209. doi: 10.1038/s41392-020-00312-6.
4
Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Theranostics. 2020 Jul 9;10(19):8606-8618. doi: 10.7150/thno.46861. eCollection 2020.
5
Functional characterization of SOX2 as an anticancer target.
Signal Transduct Target Ther. 2020 Jul 29;5(1):135. doi: 10.1038/s41392-020-00242-3.
6
The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer.
Cancer Res. 2020 Oct 1;80(19):4025-4036. doi: 10.1158/0008-5472.CAN-19-3578. Epub 2020 Jul 2.
7
Key steps for effective breast cancer prevention.
Nat Rev Cancer. 2020 Aug;20(8):417-436. doi: 10.1038/s41568-020-0266-x. Epub 2020 Jun 11.
8
NF-κB in the New Era of Cancer Therapy.
Trends Cancer. 2020 Aug;6(8):677-687. doi: 10.1016/j.trecan.2020.04.003. Epub 2020 May 11.
9
Overcoming Endocrine Resistance in Breast Cancer.
Cancer Cell. 2020 Apr 13;37(4):496-513. doi: 10.1016/j.ccell.2020.03.009.
10
Life, death, and autophagy in cancer: NF-κB turns up everywhere.
Cell Death Dis. 2020 Mar 30;11(3):210. doi: 10.1038/s41419-020-2399-y.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验